by country – Page 2 – Retraction Watch

Court orders historian to repay grant funding for “pattern of plagiarism” in books

A federal court has ordered a “romance philologist” to repay the Swiss National Science Foundation roughly $51,000 after the group found the author responsible for “massive” scientific misconduct in two grant-funded books.

Carla Rossi, scientific director of the Centro Scaligero degli Studi Danteschi in Verona, Italy, must repay the funding due to extensive plagiarism discovered in the texts, according to the decision by the Federal Administrative Court of Switzerland, released in January. Rossi also is barred from applying for grant funding from the foundation for five years, according to the ruling. Rossi is founder and director of Institut d’Estudis Filològics Dantescs i Digitals Avançats in Barcelona and also director of the Research Centre for European Philological Tradition (RECEPTIO) in Switzerland, which operates an academic press that has published Rossi’s works.

The Swiss body issued the funding ban in 2024 and ordered Rossi to repay grants for a total of three books after finding a pattern of plagiarism and lack of transparency during the grant application process, according to a summary in the court decision. Rossi took the foundation to court over the findings, arguing it reviewed incorrect versions of her books and suggesting other versions circulating on the Internet were altered or manipulated by third parties.

Another retraction and two investigations for chemist

A chemist in Austria who earned a retraction earlier this year is under investigation by his former university, a national research integrity agency and the publisher Elsevier, Retraction Watch has learned, while scrutiny of his publication record has broadened to include more papers flagged on PubPeer.

Maximilian Lackner, a technical chemist and process engineer at FH Technikum Wien in Austria until October last year, according to his ORCID profile, was the senior and corresponding author on a paper in npj Science of Food retracted in January after publishers discovered the five of the cited references weren’t relevant to the claims they were meant to be supporting. The 2024 article has been cited 90 times, according to Clarivate’s Web of Science.

Editors also pointed out the information in a flow diagram for selecting studies didn’t appear anywhere else in the article. One of the authors, Fatemeh Ahmadi of the University of Western Australia, told the journal she and Lackner disagreed with the retraction. When we asked why, Ahmadi said the authors were “not interested” in our request for further information.

Major pharmacology journals flag another 15 papers by scientist facing criminal probe

A leading pharmacologist in Italy accused of embezzling research funds is now the subject of coordinated editorial action by one of the field’s professional societies.

The American Society for Pharmacology and Experimental Therapeutics announced expressions of concern for 12 papers, corrections for two and a retraction in an editorial published April 3 in The Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology. Salvatore Cuzzocrea, a pharmacology professor at the University of Messina, was a coauthor or corresponding author on all the papers. As we reported previously, Cuzzocrea is being investigated in Italy for allegedly embezzling more than 2 million euros in research reimbursements and allegedly rigging university contracts.

Since our reporting on Cuzzocrea a year ago, journals have retracted five more of his papers. One, from BMC Neuroscience, was retracted 10 days after our reporting for containing data that appeared in an earlier publication. A different paper was retracted last year from Biology for containing overlapping images, another from Biomedicine & Pharmacotherapy for image overlaps, and the International Journal of Molecular Science retracted two more this year for containing duplications and “inappropriate editing” of micrographs.

Scientist who alleged COVID cover-up circulated a faked NIH email, agency says

A scientist charged with research misconduct used a fake email communication with an NIH researcher’s address to support his claims of governmental retaliation, Retraction Watch has learned.

Last month, we reported on the upholding of a proposed 15-year debarment by a U.S. Department of Health and Human Services appeals judge against Argentine chemist Ariel Fernández for falsifying research while a professor at Rice University in Houston. Administrative law judge Margaret G. Brakebusch based that May 2025 decision on findings by Rice sent to the Office of Research Integrity in 2010 and conclusions from ORI’s independent review completed in 2022.

Fernández denied the misconduct allegations and told us the findings were retaliation by the government for a 2021 paper he wrote supporting a lab origin of SARS-CoV-2. As evidence of the contention, Fernández showed us an email purportedly from National Institutes of Health researcher Joshua Cherry dated June 2021. The email, which appeared to be from Cherry’s NIH address, threatened to resurrect Fernández’s ORI case if he didn’t remove the paper. We could not independently verify the email’s authenticity at the time.

Canadian panel seeks to add more teeth to research oversight

*Public comment is invited through April 17, 2026.*

A Canadian panel is proposing several changes to its guidelines for responsible conduct of research, including a provision that effectively removes any statute of limitations on investigations into potential misconduct.

The proposed revisions, from the Canadian Panel on Responsible Conduct of Research (PRCR), are up for public comment until April 17 and have not been made official. The PRCR is an interdisciplinary review and advisory body to Canada’s three federal research funding agencies: the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council, and the Social Sciences and Humanities Research Council.

Could a national database of scientific misconduct rulings stop repeat offenders?

*Mark Barnes (courtesy of Ropes and Gray LLC)*

In an editorial published today in Science, Michael Lauer and Mark Barnes call for greater transparency in investigations of scientific misconduct with an aim toward making sure prospective academic employers know of applicants’ past misdeeds. As we’ve reported, in the absence of transparency around findings of misconduct, some universities have discovered too late they hired someone who has turned out to be a serial offender.

Lauer, who served as Deputy Director for Extramural Research at the National Institutes of Health from 2015-2025, and Barnes, a partner at Ropes and Gray LLC in Boston who has served as acting research integrity officer at several U.S. institutions, propose a tracking system similar to the National Practitioner Data Bank (NPDB). That database logs adverse actions and malpractice payments as a way to inform decisions about individual physicians by hospitals. As Lauer and Barnes note, federal law “requires a hospital to query the NPDB whenever it is considering a new applicant for medical privileges, as well as to conduct repeat queries every 2 years to make sure information on staff is up to date.” We asked Barnes to elaborate on the ideas presented in the op-ed. (He notes he is speaking only for himself here.)

Retraction Watch: You write in your op-ed universities may avoid sharing personal information — presumably including results of misconduct investigations — for fear of legal claims of defamation or violations of privacy. Are those fears valid?

Publisher to retract entire conference proceedings, ban editor who wrote most of them

*EPJ Web of Conferences* will retract the entire volume of conference proceedings for ICEMR 2025.

On Monday, we published a story about a physicist in India who had three papers on superheavy elements retracted after others in his field began flagging his work. Hours later, a publisher decided to retract an entire volume of conference proceedings after one of the critics pointed out the researcher, H.C. Manjunatha, was responsible for the majority of its contents.

Manjunatha is listed as coordinator of the International Conference on Emerging Frontiers in Material Science and Radiation Physics, which took place in December. Manjunatha was one of four editors for the conference’s proceedings published in EPJ Web of Conferences on March 18. Of the 55 articles in the volume, Manjunatha is an author on 32.

David Boilley, a physicist at the University of Caen Normandy and researcher at GANIL, emailed EDP Sciences, which publishes EPJ Web of Conferences, on March 22 noting Manjunatha’s position as editor and the large number of papers he authored in the volume. Boilley, whom we interviewed for our story, mentioned the forthcoming article to the journal and also included a copy of his recent preprint calling out Manjunatha’s papers.

University of Melbourne opens formal investigation into education researcher John Hattie

The University of Melbourne has opened a formal investigation into the prominent Australia-based education researcher John Hattie, backtracking on a decision months ago that concerns about his work didn’t warrant further scrutiny.

The investigation, confirmed in a letter seen by Retraction Watch, was triggered by allegations made by Stephen Vainker, a teacher and former doctoral researcher in the United Kingdom, who documented what he says are hundreds of instances of plagiarism and data errors across Hattie’s body of work. The investigation also follows our coverage last August.

Vainker also discovered what seems to be a hallucinated reference in one of Hattie’s recent writings, prompting a book publisher to remove it from the work.

A medical journal says the case reports it has published for 25 years are, in fact, fiction

A Canadian journal has issued corrections on 138 case reports it published over the last 25 years to add a disclaimer: The cases described are fictional.

Paediatrics & Child Health, the journal of the Canadian Paediatric Society, has published the cases since 2000 in articles for a series for its Canadian Paediatric Surveillance Program. The articles usually start with a case description followed by “learning points” that include statistics, clinical observations and data from CPSP. The peer-reviewed articles don’t state anywhere the cases described are fictional.

The corrections come following a January article in New Yorker magazine that mentioned one of the reports — “Baby boy blue,” a case published in 2010 describing an infant who showed signs of opioid exposure via breast milk while his mother was taking acetaminophen with codeine. The New Yorker article made public an admission by one of the coauthors that the case was made up.

Chemist nears three dozen retractions for image duplication, self-citation and more

A screenshot of Louis’ LinkedIn profile before we reached out to him.

Racking up 35 retractions in just 24 months, chemist Hitler Louis has scored a place on our leaderboard.

The papers at issue, most of them published in Elsevier and Royal Society of Chemistry journals, exhibit a variety of problems, according to the retraction notices: identical plots supposedly representing different chemical systems, self-citations multiplying between manuscript submission and publication, compromised peer review and fundamental errors in chemical analyses.

Louis – who also goes by Louis Hitler Muzong – did not respond to Retraction Watch’s requests for comment. Until recently, his LinkedIn page named him as a Ph.D. student in computational chemistry at the University of Leeds in the United Kingdom, with an expected completion date of October 2027. But retraction notices for two papers say Louis requested his Leeds affiliation be removed. One states “the research described in the article is not associated with that institution,” and the other that the affiliation “was given incorrectly.” The University of Leeds did not respond to a request to verify whether he was a student there.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: